Growth capital momentum Andera Partners is expanding across multiple strategic sectors (life sciences, growth/buyout, sponsorless transactions, ecological transition) with recent investments and regional activity in Europe, signaling continued appetite for capital deployment to high-potential companies.

Healthcare tech signals Recent investment in Rivermark Medical and Spiro Medical demonstrates active interest in medical devices and neuromodulation tech for respiratory and urinary health, suggesting opportunities with startups and growth-stage firms in medtech and digital health.

International expansion With offices in Paris, Antwerp, Madrid, Milan, and Munich and a growing Spain advisory footprint, Andera Partners is positioned to source cross-border deals and partner with European-scale founders seeking multi-market support.

Awarded platform strength Recognition as Best Multi-Strategy House of the Year reinforces credibility with LPs and portfolio companies, enabling easier access to co-investors and potential deal partnerships for accelerations or co-led financings.

Strategic exits & monetization Recent asset sale to iris energy and a diversified fund尚 suggests a pragmatic exit capability and a breadth of sponsorless and traditional deals, offering opportunities to engage in advisory roles, co-investments, or exit sequencing for portfolio targets.